Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrografin and NGT in Adhesive Small Bowel Obstruction
NCT06182319Phase 3Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diatrizoate meglumine + diatrizoate sodium in Adhesive small bowel obstruction (ASBO), sponsored by University of California, Los Angeles. Started Jan 2024; status: recruiting.
02
Drugs
diatrizoate meglumine + diatrizoate sodium
03
Conditions
Adhesive small bowel obstruction (ASBO)
Beyond the preview
Go deeper on NCT06182319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06182319.